1. An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. Issue 3 (March 2017) Authors: Patel, Radhika; Barker, Holly E.; Kyula, Joan; McLaughlin, Martin; Dillon, Magnus T.; Schick, Ulrike; Hafsi, Hind; Thompson, Alan; Khoo, Vincent; Harrington, Kevin; Zaidi, Shane Journal: Radiotherapy and oncology Issue: Volume 122:Issue 3(2017:Mar.) Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation. Issue 1 (December 2016) Authors: Chkioua, Latifa; Khedhiri, Souhir; Hafsi, Hind; Grissa, Oussama; Ben Turkia, Hadhami; Miled, Abdelhedi; Laradi, Sandrine; Froissart, Roseline; Alif, Najat Journal: Diagnostic pathology Issue: Volume 11:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P53, stem cell biology and childhood blastomas. Issue 2 (March 2019) Authors: Oh, Lixian; Hafsi, Hind; Hainaut, Pierre; Ariffin, Hany Journal: Current opinion in oncology Issue: Volume 31:Issue 2(2019:Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence. Issue 2 (November 2015) Authors: Schick, Ulrike; Kyula, Joan; Barker, Holly; Patel, Radhika; Zaidi, Shane; Gregory, Claire; Hafsi, Hind; Roulstone, Victoria; Deutsch, Eric; McLaughlin, Martin; Harrington, Kevin Journal: Radiotherapy and oncology Issue: Volume 117:Issue 2(2015:Nov.) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗